One day following a rport in The New York Times, Sanifo-Aventis, manufacturer of Ketek, suspended the trial in children. The FDA has not announced any action.

Read More

Bbioethicists are seizing the opportunity to expand their own marketability.  The UK publication, NATURE, reports about the latest bioethics gimmick that has sprung up in California– ‘dial-an-ethicist’—at the Stanford Center for Biomedical Ethics.

Read More